MedTrace Logo

Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting

NCT00395785 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2007-07-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of the TriActiv® ProGuard™ System when used during a stent placement in a blockage within the carotid artery in patients considered to be at high risk for complications from surgical endarterectomy.

Conditions

  • Carotid Stenosis

Interventions

DEVICE

Carotid Stent Implantation

DEVICE

Embolic Protection

Sponsors & Collaborators

  • Kensey Nash Corporation

    lead INDUSTRY

Principal Investigators

  • Gary S Roubin, MD · Lenox Hill Hospital, New York, NY

  • Rajesh Dave, MD · Pinnacle Health Hospital, Harrisburg, PA

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Completion
2007-06-30

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00395785 on ClinicalTrials.gov